Rifaximin and Placebo in the Treatment of Bowel Dysfunction After Anterior Resection for Rectal Cancer
NCT01345175
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
69
Enrollment
OTHER
Sponsor class
Conditions
Rectal Cancer
Interventions
DRUG:
Rifaximin
DRUG:
Placebo
Sponsor
Memorial Sloan Kettering Cancer Center